Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination With Gemcitabine

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-20004-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anti-Estrogenic Actions of Histone Deacetylase Inhibitors in McF-7 Breast Cancer Cells

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Histone Deacetylase 6 (HDAC6); Histone Deacetylase 8 (HDAC8)

Science-Business eXchange
2013English

Histone Deacetylase Inhibition Elicits an Evolutionarily Conserved Self-Renewal Program in Embryonic Stem Cells

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2009English

The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer With Low Xist Expression

Clinical Cancer Research
Cancer ResearchOncology
2013English

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells

Cancers
Cancer ResearchOncology
2019English

Histone Deacetylase HDAC1/HDAC2-controlled Embryonic Development and Cell Differentiation

International Journal of Developmental Biology
EmbryologyDevelopmental Biology
2009English

Checkpoint With Forkhead and Ring Finger Domains (CHFR); Histone Deacetylase 1 (HDAC1)

Science-Business eXchange
2009English

YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine

Nutrients
NutritionFood ScienceDietetics
2016English

Histone Deacetylase 1 (HDAC1) Regulates Histone Acetylation, Development, and Gene Expression in Preimplantation Mouse Embryos

Developmental Biology
Developmental BiologyCell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy